Sleeping Bruxism Treatment Market Size and Forecast, by Product Type (Mouth Guards, NTI-tss and Splints); Patient Type, End user - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 6939
  • Published Date: Aug 13, 2025
  • Report Format: PDF, PPT

Sleeping Bruxism Treatment Market Outlook:

Sleeping Bruxism Treatment Market size was over USD 559.87 million in 2025 and is poised to exceed USD 877.82 million by 2035, growing at over 4.6% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of sleeping bruxism treatment is estimated at USD 583.05 million.

Key Sleeping Bruxism Treatment Market Insights Summary:

  • North America dominates the Sleeping Bruxism Treatment Market with a 39.5% share, driven by rising bruxism cases, stress awareness, and innovations in diagnostic and non-invasive treatment options, ensuring leadership through 2026–2035.

  • The Asia Pacific sleeping bruxism treatment market is forecasted for rapid growth through 2035, driven by increasing stress-related disorders, improved awareness, and enhanced access via telehealth services.

  • The NTI-tss and splints segment of the Sleeping Bruxism Treatment Market is expected to capture a 62.30% share by 2035, driven by its proven effectiveness in managing teeth grinding and jaw clenching.

  • Key Growth Trends:

    • Increasing adoption of botulinum toxin therapy
    • Growing demand for non-invasive treatments
  • Major Challenges:

    • High cost of advanced treatment
    • Dependance on behavioral compliance
  • Key Players: Carestream Dental, Akervall Technologies Inc., Planmeca Oy.

Market Size and Growth Projections:

  • 2025 Market Size: USD 559.87 million
  • 2026 Market Size: USD 583.05 million
  • Projected Market Size: USD 877.82 million by 2035
  • Growth Forecasts: 4.6% CAGR (2026-2035)
  • Largest Region: North America (39.5% Share by 2035)
  • Fastest Growing Region: Asia Pacific
  • Dominating Countries: United States, Canada, Germany, United Kingdom, Japan
  • Emerging Countries: China, India, Japan, South Korea, Brazil

Modern lifestyles, characterized by demanding work schedules, digital connectivity, and societal pressures, have significantly contributed to rising stress and anxiety levels worldwide. These factors are recognized as primary causes of sleeping bruxism, leading to a higher prevalence of the condition. In July 2024, the National Library of Medicine reported that 21% of people worldwide suffer from sleep bruxism, whereas 23% of people suffer from it while awake. Polysomnography was used to estimate the prevalence of sleep bruxism at 43%. Consequently, there is a growing demand for effective treatment options such as behavioral interventions, stress management techniques, and medications. These therapies aim to alleviate bruxism symptoms by addressing its underlying psychological triggers.

Additionally, the increasing prevalence of sleep disorders, such as obstructive sleep apnea, which is frequently fueled the demand for sleeping bruxism treatment market. In February 2024, the National Library of Medicine reported that the prevalence of sleep disorders doubled over ten years, rising from 3 867 975 (7.62%) in 2011 to 7 446 846 (14.41%) in 2020. These conditions often co-exist, creating a need for comprehensive approaches that address both simultaneously. Healthcare providers are prioritizing holistic treatment plans, combining therapies such as dental appliances, continuous positive airway pressure (CPAP) devices, and behavioral interventions, ensuring effective management of both sleep apnea and bruxism for improved patient outcomes.

Sleeping Bruxism Treatment Market Size
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

Growth Drivers  

  • Increasing adoption of botulinum toxin therapy: The application of botulinum toxin (Botox) has emerged as a highly effective solution for managing severe cases of bruxism, gaining widespread popularity. By targeting and reducing excessive jaw muscle activity, Botox helps alleviate pain, prevent dental damage, and improve overall quality of life. As published in the National Library of Medicine in January 2024, the social domain improved significantly from 65.3 to 73.4 over 12 months with botulinum toxin therapy. Its minimally invasive nature, quick administration, and long-lasting effects make it for an appealing choice for patients seeking effective treatment, driving increased adoption among healthcare providers and patients alike. Thus, propelling the sleeping bruxism treatment market.
  • Growing demand for non-invasive treatments: Patients are increasingly opting for non-invasive or minimally invasive treatments to manage bruxism, prioritizing options that offer effective results without the risks associated with surgery. Therapies such as behavioral interventions, relaxation techniques, and medications are gaining traction due to their convenience, safety, and focus on addressing underlying causes. This shift in preference has significantly boosted the demand for these solutions, as they cater to the growing need for personalized and less intrusive treatment approaches, in turn, propagating the sleeping bruxism treatment market.

Challenge

  • High cost of advanced treatment: Advanced solutions for bruxism treatment, such as custom-made dental appliances and botulinum toxin therapy, can be prohibitively expensive, making them less accessible for patients with lower disposable incomes. The high cost of these treatments often acts as a barrier, causing patients to delay or forgo seeking professional care. As a result, the adoption rate in the sleeping bruxism treatment market is impacted, and many individuals continue to suffer from untreated bruxism-related symptoms.
  • Dependance on behavioral compliance: Non-invasive treatments for bruxism, such as stress management and behavioral therapy, rely heavily on consistent patient effort and compliance to the effective. Patients must actively engage in techniques like relaxation exercises and cognitive behavioral therapy to achieve meaningful results. However, lack of adherence to these interventions due to factors like time constraints, lifestyle challenges, or lack of motivation can significantly reduce the success rates of treatments and, in turn, limit overall sleeping bruxism treatment market growth.

Sleeping Bruxism Treatment Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Period

2026-2035

CAGR

4.6%

Base Year Market Size (2025)

USD 559.87 million

Forecast Year Market Size (2035)

USD 877.82 million

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Sleeping Bruxism Treatment Market Segmentation:

Product Type (Mouth Guards, NTI-tss and Splints)

By product type, the NTI-tss and Splints segment is estimated to capture around 62.3% sleeping bruxism treatment market share by the end of 2035. The segment’s growth is due to its proven effectiveness in managing teeth grinding and jaw clenching. NTI-tss devices specifically target the trigeminal nerve to reduce muscle tension, while custom-made splints protect teeth from damage. For instance, in June 2021, Glidewell launched NTI-tss Plus and the NTI OmniSplint. These FDA-approved dental supplies can minimize clenching forces by about 70%. These treatments offer non-invasive, comfortable solutions that align with patient preferences, making them increasingly popular and driving the market demand.

Patient Type (Adult, Pediatric)

Based on patient type, the adult segment is anticipated to hold the majority sleeping bruxism treatment market share over the forecast period. The segment is growing due to increasing stress, anxiety, and lifestyle factors, such as long working hours and sleep disorders, prevalent in adult populations. According to a Sleep Foundation article, published in April 2024, bruxing is more common in younger adults who may exert around 250 pounds of pure force while grinding. In addition, 8% of middle-aged and 3% of other adults are estimated to suffer from this condition. As awareness about the harmful effects of untreated bruxism, such as tooth damage and jaw issues, rises, more adults are seeking treatment. The availability of non-invasive solutions, such as mouthguards and biofeedback devices, further contributes to the growth of sleeping bruxism treatment.

Our in-depth analysis of the global market includes the following segments:

Product Type

  • Mouth Guards
  • NTI-tss and Splints

Patient Type

  • Adult
  • Pediatric

End User

  • Hospitals
  • Dental clinics
  • Homecare settings
  • Others 
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.


Sleeping Bruxism Treatment Market Regional Analysis:

North America Market Statistics

North America sleeping bruxism treatment market is poised to dominate revenue share of around 39.5% by the end of 2035. Rising cases of sleeping bruxism, often associated with stress, anxiety, and changing lifestyles, are significantly increasing the demand for effective treatment options. Growing awareness about the condition’s potential long-term effects, including tooth damage, jaw disorders, and chronic pain, has prompted more individuals to seek timely medical advice and solutions. Innovative diagnostics and treatments, such as portable sleep monitors, custom mouthguards, and biofeedback devices, ensure accurate detection and effective management.

Stress-related disorders, frequently intensified by hectic work environments, societal pressures, and modern lifestyles, are significant contributors to the rise in bruxism cases. Growing awareness of mental health in the U.S. has prompted more individuals to seek help for stress-induced conditions such as bruxism, leading to increased demand for effective treatment options and solutions. Additionally, wearable devices monitoring jaw activity during sleep revolutionize bruxism management, improving treatment adherence and outcomes, and marking progress in the sleeping bruxism treatment market.

In Canada, patients are showing a growing preference for non-invasive solutions, including custom-made mouthguards, biofeedback devices, and behavioral therapies. These options offer effective management of sleep bruxism without requiring surgical or pharmaceutical interventions, catering to patient demands for safer, more comfortable, and convenient treatment methods, driving the sleeping bruxism treatment market growth. For instance, in April 2021, the acquisition of an exclusive license to register, market, and commercialize a botulinum toxin (DTX-021) in the US and Canada was announced by Aquavit Holdings LLC. Furthermore, emphasis on oral health boosts demand for dental check-ups, early bruxism detection, and customized treatments.

Asia Pacific Market Analysis

The Asia Pacific sleeping bruxism treatment market is established to garner the fastest CAGR over the forecast period. The rising prevalence of sleeping bruxism in the Asia Pacific region, fueled by stress, anxiety, and a fast-paced lifestyle, is a key factor driving market growth. Educational campaigns and increased awareness about the negative effects on oral health and overall well-being are motivating individuals to seek timely diagnosis and effective treatment options. Telehealth platforms in the Asia Pacific enhance access to bruxism treatments, especially in rural areas, driving therapy adoption regionwide.

The rising incidence of sleep disorders, including insomnia and sleep apnea, in China, has heightened awareness of bruxism as a related condition. In August 2023, the National Library of Medicine reported that sleep disorders are found in 8.96 to 49.90% of Chinese people in various locations. As more people seek treatment for sleep issues, there is an increased recognition of bruxism’s role in overall sleep health, driving the demand for targeted therapies and treatment options for bruxism. Modern diagnostic tools, including sleep monitors and imaging technologies, enable early, precise bruxism detection, driving effective treatments and sleeping bruxism treatment market growth.

Rapid urbanization in India is leading to increasingly stressful lifestyles, with long working hours, high expectations, and societal pressures. The combined estimates for the prevalence of insomnia, OSA, and RLS were 25.7%, 37.4%, and 10.6%, respectively, as of December 2023. This rising stress significantly contributes to sleep-related disorders such as bruxism, causing a higher demand for effective treatment options as more individuals seek to manage these conditions. Additionally, the expanding middle class and higher disposable income are driving increased spending on healthcare, boosting the adoption of bruxism treatments in urban areas. Thus, propelling the sleeping bruxism treatment market.

Sleeping Bruxism Treatment Market Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Key Sleeping Bruxism Treatment Market Players:

    Key companies in the sleeping bruxism treatment market are innovating by developing advanced solutions like custom-made mouthguards, biofeedback devices, and wearable technologies. These innovations enable more effective management by offering personalized treatments, real-time monitoring, and non-invasive options. Companies are also enhancing diagnostic tools, such as portable sleep monitors, to facilitate early detection, driving growth by improving treatment outcomes and patient adherence. These companies are:

    • Randmark Dental Products, LLC.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Ivoclar Vivadent AG
    • Ipsen S.A.
    • Merz Pharma GmbH & Co. KGaA
    • Carestream Dental
    • Akervall Technologies Inc
    • Planmeca Oy
    • S4S Limited
    • Patterson Dental Supply, Inc
    • Henry Schein, Inc
    • Pfizer, Inc
    • GC International AG
    • ALIGNERCO

Recent Developments

  • In July 2024, ALIGNERCO launched a series of new mouthguards, night guards, and retainers. The custom hybrid night guard was designed to capture consumers with a limited budget, providing comfortable and effective protection against grinding, clenching, and bruxism. 
  • In November 2021, the FDA approved SprintRay’s NightGuard Flex resin, a Class II device for bruxism treatment.
  • Report ID: 6939
  • Published Date: Aug 13, 2025
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of sleeping bruxism treatment is estimated at USD 583.05 million.

Sleeping Bruxism Treatment Market size was over USD 559.87 million in 2025 and is poised to exceed USD 877.82 million by 2035, growing at over 4.6% CAGR during the forecast period i.e., between 2026-2035.

North America dominates the Sleeping Bruxism Treatment Market with a 39.5% share, driven by rising bruxism cases, stress awareness, and innovations in diagnostic and non-invasive treatment options, ensuring leadership through 2026–2035.

Key players in the market include Carestream Dental, Akervall Technologies Inc., Planmeca Oy.
GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.


Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos